Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer: Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

Peter W.T. Pisters; Douglas B. Evans

doi:10.1097/SLA.0b013e3181820d35

Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer: Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

Peter W.T. Pisters, Douglas B. Evans

Surgical Oncology

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	152-153
Number of pages	2
Journal	Annals of surgery
Volume	248
Issue number	2
DOIs	https://doi.org/10.1097/SLA.0b013e3181820d35
State	Published - Aug 2008

ASJC Scopus subject areas

Surgery

Access to Document

10.1097/SLA.0b013e3181820d35

Cite this

Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer: Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? / Pisters, Peter W.T.; Evans, Douglas B.
In: Annals of surgery, Vol. 248, No. 2, 08.2008, p. 152-153.

Research output: Contribution to journal › Editorial › peer-review

@article{3eee172aa23f4c5db3ad17ce60aa4ebd,

title = "Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer: Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?",

author = "Pisters, {Peter W.T.} and Evans, {Douglas B.}",

year = "2008",

month = aug,

doi = "10.1097/SLA.0b013e3181820d35",

language = "English (US)",

volume = "248",

pages = "152--153",

journal = "Annals of surgery",

issn = "0003-4932",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer

T2 - Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

AU - Pisters, Peter W.T.

AU - Evans, Douglas B.

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=49849088623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849088623&partnerID=8YFLogxK

U2 - 10.1097/SLA.0b013e3181820d35

DO - 10.1097/SLA.0b013e3181820d35

M3 - Editorial

C2 - 18650622

AN - SCOPUS:49849088623

SN - 0003-4932

VL - 248

SP - 152

EP - 153

JO - Annals of surgery

JF - Annals of surgery

IS - 2

ER -

Cisplatin, fluorouracil, interferon-α, and radiation as adjuvant therapy for resected pancreatic cancer: Is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this